© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
AAAAI 2023: Pediatric Asthma Risk Score Validated in Multi-cohort Study
February 23rd 2023
Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.
For Persons with Asthma Infected with COVID-19, Systemic Corticosteroid Prescribing is Up
February 23rd 2023
AAAAI 2023. Pandemic prescribing rates for systemic corticosteroids increased from Alpha to Delta to Omicron waves of COVID-19 but hospitalizations have dropped, study finds.
Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds
November 9th 2022
AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.
Sotagliflozin Cuts Risk by >50% for Heart Failure Readmission, CV Death in Phase 3 SOLOIST-WHF Trial
November 9th 2022
In the SOLOIST-WHF trial, risk for HF readmission and CV death were reduced by more than 50% at 30- and 90-days after hospital discharge.
Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes
November 4th 2022
AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.
Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds
November 2nd 2022
AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.
Perceived Discrimination Impairs Post-MI Recovery in Young Adults, Study Warns
November 2nd 2022
AHA 2022. A perception of discrimination was associated with worse mental health and disease-related health status 1 year post-MI among adults aged ≤55 years.
Tirzepatide Led to Clinically Meaningful Improvements in Body Composition in Adults with Obesity/Overweight
November 1st 2022
ObesityWeek 2022: Tirzepatide-induced weight reduction was associated with body composition improvements in adults with obesity/overweight, found analysis of SURMOUNT-1.
Physicians Should Get Patients to Move More to Help with Cardiometabolic Health, Says One Expert
October 26th 2022
Cardiometabolic Health Congress
To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.
High- vs Standard-dose Dexamethasone Could Pose Risks for Ventilated COVID-19 Patients
October 25th 2022
High-dose dexamethasone is often prescribed for critically ill COVID-19 patients although there is no evidence for its efficacy. A new study looked deeper.